Literature DB >> 22079576

Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.

B N Cohen1, E D W Mackey, S R Grady, S McKinney, N E Patzlaff, C R Wageman, J M McIntosh, M J Marks, H A Lester, R M Drenan.   

Abstract

Firing rates of dopamine (DA) neurons in substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) control DA release in target structures such as striatum and prefrontal cortex. DA neuron firing in the soma and release probability at axon terminals are tightly regulated by cholinergic transmission and nicotinic acetylcholine receptors (nAChRs). To understand the role of α6* nAChRs in DA transmission, we studied several strains of mice expressing differing levels of mutant, hypersensitive (leucine 9' to serine [L9'S]) α6 subunits. α6 L9'S mice harboring six or more copies of the hypersensitive α6 gene exhibited spontaneous home-cage hyperactivity and novelty-induced locomotor activity, whereas mice with an equal number of WT and L9'S α6 genes had locomotor activity resembling that of control mice. α6-dependent, nicotine-stimulated locomotor activation was also more robust in high-copy α6 L9'S mice versus low-copy mice. In wheel-running experiments, results were also bi-modal; high-copy α6 L9'S animals exhibited blunted total wheel rotations during each day of a 9-day experiment, but low-copy α6 L9'S mice ran normally on the wheel. Reduced wheel running in hyperactive strains of α6 L9'S mice was attributable to a reduction in both overall running time and velocity. ACh and nicotine-stimulated DA release from striatal synaptosomes in α6 L9'S mice was well-correlated with behavioral phenotypes, supporting the hypothesis that augmented DA release mediates the altered behavior of α6 L9'S mice. This study highlights the precise control that the nicotinic cholinergic system exerts on DA transmission and provides further insights into the mechanisms and consequences of enhanced DA release.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079576      PMCID: PMC3249511          DOI: 10.1016/j.neuroscience.2011.10.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Putting a spin on the dorsal-ventral divide of the striatum.

Authors:  Pieter Voorn; Louk J M J Vanderschuren; Henk J Groenewegen; Trevor W Robbins; Cyriel M A Pennartz
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

3.  Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals.

Authors:  Maria Ballester; Anna Castelló; Elena Ibáñez; Armand Sánchez; Josep M Folch
Journal:  Biotechniques       Date:  2004-10       Impact factor: 1.993

4.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

5.  Alterations in acetylcholine release in the rat hippocampus during sleep-wakefulness detected by intracerebral dialysis.

Authors:  H Kametani; H Kawamura
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

Review 6.  Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

Authors:  Maryka Quik; J Michael McIntosh
Journal:  J Pharmacol Exp Ther       Date:  2005-10-06       Impact factor: 4.030

7.  Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Authors:  Ryan M Drenan; Sharon R Grady; Andrew D Steele; Sheri McKinney; Natalie E Patzlaff; J Michael McIntosh; Michael J Marks; Julie M Miwa; Henry A Lester
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

8.  Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.

Authors:  Cecilia Gotti; Milena Moretti; Francesco Clementi; Loredana Riganti; J Michael McIntosh; Allan C Collins; Michael J Marks; Paul Whiteaker
Journal:  Mol Pharmacol       Date:  2005-03-04       Impact factor: 4.436

Review 9.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

10.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

View more
  26 in total

1.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

2.  Why flavored vape products may be attractive: Green apple tobacco flavor elicits reward-related behavior, upregulates nAChRs on VTA dopamine neurons, and alters midbrain dopamine and GABA neuron function.

Authors:  Alicia J Avelar; Austin T Akers; Zachary J Baumgard; Skylar Y Cooper; Gabriella P Casinelli; Brandon J Henderson
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

3.  α6β2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty.

Authors:  Cody A Siciliano; J Michael McIntosh; Sara R Jones; Mark J Ferris
Journal:  Neuropharmacology       Date:  2017-06-27       Impact factor: 5.250

4.  Nicotine Dependence Reveals Distinct Responses from Neurons and Their Resident Nicotinic Receptors in Medial Habenula.

Authors:  Pei-Yu Shih; J Michael McIntosh; Ryan M Drenan
Journal:  Mol Pharmacol       Date:  2015-10-01       Impact factor: 4.436

5.  Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors.

Authors:  Staci E Engle; J Michael McIntosh; Ryan M Drenan
Journal:  Neuropharmacology       Date:  2014-12-04       Impact factor: 5.250

Review 6.  Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations.

Authors:  Ryan M Drenan; Henry A Lester
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

7.  Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours.

Authors:  M S Powers; H J Broderick; R M Drenan; J A Chester
Journal:  Genes Brain Behav       Date:  2013-05-07       Impact factor: 3.449

8.  α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity.

Authors:  J N Berry; S E Engle; J M McIntosh; R M Drenan
Journal:  Neuroscience       Date:  2015-07-23       Impact factor: 3.590

9.  A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.

Authors:  Lindsey G Soll; Sharon R Grady; Outi Salminen; Michael J Marks; Andrew R Tapper
Journal:  Neuropharmacology       Date:  2013-05-17       Impact factor: 5.250

10.  α6* nicotinic acetylcholine receptor expression and function in a visual salience circuit.

Authors:  Elisha D W Mackey; Staci E Engle; Mi Ran Kim; Heidi C O'Neill; Charles R Wageman; Natalie E Patzlaff; Ying Wang; Sharon R Grady; J Michael McIntosh; Michael J Marks; Henry A Lester; Ryan M Drenan
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.